DANVERS, Mass.--(BUSINESS WIRE)--May 29, 2019--
Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart
support technologies, today announced that Michael R. Minogue, Chairman,
President and Chief Executive Officer, will present at two upcoming
- Jefferies Global Healthcare Conference on Tuesday, June 4, 2019 at
4:30pm ET. The conference will be held at Grand Hyatt, New York, NY.
- William Blair Growth Conference on Wednesday, June 5, 2019 at 12:40pm
CT. The conference will take place at the Loews Hotel, Chicago, IL.
Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of
medical devices that provide circulatory support. Our products are
designed to enable the heart to rest by improving blood flow and/or
performing the pumping of the heart. For additional information, please
This release contains forward-looking statements, including statements
regarding development of Abiomed's existing and new products, the
Company's progress toward commercial growth, and future opportunities
and expected regulatory approvals. The Company's actual results may
differ materially from those anticipated in these forward-looking
statements based upon a number of factors, including uncertainties
associated with development, testing and related regulatory approvals,
including the potential for future losses, complex manufacturing, high
quality requirements, dependence on limited sources of supply,
competition, technological change, government regulation, litigation
matters, future capital needs and uncertainty of additional financing,
and other risks and challenges detailed in the Company's filings with
the Securities and Exchange Commission, including the most recently
filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
Readers are cautioned not to place undue reliance on any forward-looking
statements, which speak only as of the date of this release. The Company
undertakes no obligation to publicly release the results of any
revisions to these forward-looking statements that may be made to
reflect events or circumstances that occur after the date of this
release or to reflect the occurrence of unanticipated events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190529005603/en/
Source: Abiomed, Inc.
Ingrid Goldberg Ward
Director, Investor Relations